Kyongbo Pharmaceutical Co Ltd (214390) — Long-term Investment Intensity
Kyongbo Pharmaceutical Co Ltd (214390) has a Long-term Investment Intensity of 2.7% as of December 2019. Long-term investments of ₩6.32 Billion represent 2.7% of total assets of ₩237.82 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Kyongbo Pharmaceutical Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Kyongbo Pharmaceutical Co Ltd Long-term Investment Intensity (2014–2019)
This chart shows how Kyongbo Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2019. As of December 2019, the intensity stands at 2.7%, reflecting long-term investments of ₩6.32 Billion against total assets of ₩237.82 Billion KRW. Explore 214390 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Kyongbo Pharmaceutical Co Ltd (2014–2019)
The table below presents the year-by-year Long-term Investment Intensity for Kyongbo Pharmaceutical Co Ltd from 2014 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Kyongbo Pharmaceutical Co Ltd market cap and net worth.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 2.7% | ₩6.32 Billion | ₩237.82 Billion | ▲ +2.0 pp |
| 2018 | 0.6% | ₩1.41 Billion | ₩221.62 Billion | ▲ +0.0 pp |
| 2017 | 0.6% | ₩1.22 Billion | ₩204.87 Billion | ▼ -0.9 pp |
| 2016 | 1.4% | ₩2.95 Billion | ₩203.74 Billion | ▼ 0.0 pp |
| 2015 | 1.5% | ₩2.88 Billion | ₩195.49 Billion | ▲ +0.1 pp |
| 2014 | 1.3% | ₩2.26 Billion | ₩168.03 Billion | — |